You are here

Article metrics

Article menu

Download PDFPDF

Immune cell therapies and immune cell engineering
Original research
Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapy

 

Online download statistics by month:

Online download statistics by month: March 2022 to September 2025

AbstractFullPdf
Mar 2022719752286
Apr 2022595637199
May 2022414451154
Jun 2022447479135
Jul 2022392406109
Aug 202229129574
Sep 2022336340103
Oct 202230831489
Nov 202224624876
Dec 202217617651
Jan 2023218220112
Feb 202318919177
Mar 202321821989
Apr 202314814947
May 202315615770
Jun 202316716890
Jul 202316316555
Aug 202319019095
Sep 202318118169
Oct 202317417471
Nov 202318018258
Dec 2023192196106
Jan 202413914066
Feb 202414915378
Mar 2024230230182
Apr 2024190190106
May 202420320690
Jun 202421321572
Jul 202420520979
Aug 2024154152203
Sep 202418018076
Oct 202420020493
Nov 202420420686
Dec 2024245251106
Jan 202519319573
Feb 202530430478
Mar 202517918087
Apr 2025260260113
May 202517417686
Jun 2025878742
Jul 2025110
Sep 2025110
Total961198303931